5 results
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... #Pharmacology #Management ... #Clostridium #CDifficile ... IDSA2017 #Adjunct #Antibiotics
Antiphospholipid Syndrome (APS)
APS is a rare autoimmune disorder characterized by recurring blood clots resulting from antibodies
Syndrome (APS) ... (aß2-GPl) The origin ... to be present Treatment ... #Syndrome #APS ... #diagnosis #management
Systemic Inflammatory Response Syndrome (SIRS)
•	Non-specific (infections vs non-infectious)
•	≥2 of the following:
o	Temp >38°C or <36°C
o	HR >90 bpm
o	RR
Inflammatory Response Syndrome ... >2 mmol/L Management ... Sepsis Campaign Guidelines ... recognition & treatment ... Broad-spectrum antibiotics
IDSA - Approach to Treating a Patient With Diabetic Foot Osteomyelitis
When to consider a trial of
IDSA - Approach ... of nonsurgical treatment ... Persistent sepsis syndrome ... #nonoperative #management ... #IDSA
Probiotics Guidelines
Adults with C difficile infection
 • Recommendation: Only in the context of a clinical trial
Probiotics Guidelines ... and children on antibiotic ... treatment • Recommendation ... irritable bowel syndrome ... recommendations #management